| Literature DB >> 32711435 |
Ornuma Bunkarn1, Kiatkamjorn Kusol1, Thidarat Eksirinimit1.
Abstract
OBJECTIVE: The purpose of this research was to examine the effect of a self-efficacy enhancement program on perceived self-efficacy and cervical cancer screening among women.Entities:
Keywords: Self-Efficacy Enhancement Program; Women; cervical cancer screening
Mesh:
Year: 2020 PMID: 32711435 PMCID: PMC7573414 DOI: 10.31557/APJCP.2020.21.7.2075
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
General Data of the Study Participants (n= 130)
| Variables | Total | Control | Experiment |
|
|---|---|---|---|---|
| (n = 130) | (n = 65) | (n = 65) | ||
| Number (%) | Number (%) | Number (%) | ||
| (Min = 30, Max = 60, Mean = 44.51, SD = 8.27) Age | ||||
| 30 – 40 year | 48 (36.9) | 25 (38.5) | 23 (35.4) | 0.91 |
| 41 – 50 year | 45 (34.6) | 21 (32.3) | 24 (36.9) | |
| 51 – 60 year | 37 (28.5) | 19 (29.2) | 18 (27.7) | |
| Marital status | ||||
| Married | 103 (79.3) | 54 (83.0) | 49 (75.3) | 0.59 |
| Single/Divorced/Separated | 27 (20.7) | 11 (16.9) | 16 (6.24) | |
| Religion | ||||
| Buddha | 125 (96.2) | 63 (96.9) | 62 (95.4) | 1 |
| Islamic | 3 (2.3) | 2 (3.1) | 1 (1.5) | |
| Christ | 2 (1.5) | - | 2 (3.1) | |
| Education level | ||||
| Primary education | 93 (71.5) | 49 (75.4) | 44 (67.7) | 1 |
| Secondary education | 27 (20.8) | 16 (24.6) | 11 (16.9) | |
| Diploma /Bachelor Degree | 10 (7.7) | - | 10 (15.4) | |
| Channels received news about cervical cancer | ||||
| Health volunteers | 88 (34.2) | 45 (37.2) | 43 (34.4) | 0.88 |
| Health care teams | 74 (28.8) | 38 (31.4) | 36 (29.6) | |
| Television/radio/ close person | 66 (26.7) | 31 (25.6) | 35 (28.0) | |
| Leaflet | 17 (2.3) | 7 (5.8) | 10 (8.0) | |
| Medical history of Vaginitis, Leukorrhea, or post intercourse bleeding | ||||
| No | 109 (83.8) | 53 (81.5) | 56 (85.2) | 0.12 |
| Yes | 21 (16.2) | 12 (18.5) | 9 (13.8) | |
| Reasons behind not receiving cervical cancer screenings | ||||
| A lack time for screening | 63 (29.8) | 32 (29.4) | 31 (30.4) | 0.13 |
| Shy health care provider | 59 (28.0) | 33 (30.3) | 26 (25.5) | |
| Fear of abnormality detection | 35 (16.7) | 15 (13.8) | 20 (19.6) | |
| Fear of pain | 29 (13.7) | 13 (11.8) | 16 (15.7) | |
| Lack of knowledge | 25 (11.8) | 16 (14.7) | 9 (8.8) | |
p > 0.05 (Independent t-test, Chi-square, and Fisher’s exact test)
Comparison of Mean Scores and Level of Self-Efficacy Pre-Intervention between the Experimental and the Control Groups Both in Each Dimension and Overall (n = 130)
| Self-efficacy | Experimental | Control |
| ||
|---|---|---|---|---|---|
| Mean (SD) | Level | Mean (SD) | Level | ||
| 1. Strength Dimension | 2.20 (.53) | Low | 2.27 (.49) | Low | 0.45 |
| 2. Generality Dimension | 2.10 (.51) | Low | 2.20 (.45) | Low | 0.22 |
| 3. Magnitude Dimension | 2.23 (.56) | Low | 2.18 (.53) | Low | 0.65 |
| Total | 2.18 (.40) | Low | 2.22 (.39) | Low | 0.54 |
Comparison of Mean Scores and Level of Self-Efficacy Post-Intervention between the Experimental and the Control Groups Both in Each Dimension and Overall (n = 130)
| Self-efficacy | Experimental | Control |
| ||
|---|---|---|---|---|---|
| Mean (SD) | Level | Mean (SD) | Level | ||
| 1. Strength Dimension | 3.92 (.61) | High | 2.34 (.50) | Moderate | 0.001*** |
| 2. Generality Dimension | 4.23 (.47) | High | 2.29 (.56) | Low | 0.001*** |
| 3. Magnitude Dimension | 4.21 (.46) | High | 2.20 (.45) | Low | 0.001*** |
| Total | 4.11 (.44) | High | 2.28 (.42) | Low | 0.001*** |
***p < 0.001 (Independent t-test)
Compare the Number of Screening among Women after Using the Self-Efficacy Enhancement Program
| Cervical cancer screening | Week 1 | Week 2 | Week 3 | Week 4 | Total |
|---|---|---|---|---|---|
| Number (%) | Number (%) | (%) Number | Number (%) | Number (%) | |
| Experimental | 61 (93.9) | 3 (4.6) | - | - | 64 (98.5) |
| Control | 8 (12.3) | - | - | - | 8 (12.3) |
Comparison of Cervical Screening Rates of the Sample Groups after the Self-Efficacy Enhancement Program (n = 130)
| Cervical cancer screening | Number (%) |
| |
|---|---|---|---|
| Come to screening | Not come for screening | ||
| Experimental | 64 (98.5) | 1 (1.5) | 0.001*** |
| Control | 8 (12.3) | 57 (87.7) | |
P< 0.001 (Chi- square test)***